Hospital de Santa Maria MHM is a public Central Hospital serving the Greater Lisbon area as part of the Northern Lisbon University Hospital Centre, a State-owned enterprise. Santa Maria is the largest hospital in Lisbon and indeed in Portugal.

During the past decade, Hospital de Santa Maria conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 29 clinical trials were completed, i.e. on average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 16 clinical trials were completed. i.e. 76.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Santa Maria" #1 sponsor was "Abbott Medical Devices" with 10 trials, followed by "Celgene" with 5 trials sponsored, "Gilead Sciences" with 5 trials sponsored, "Ipsen" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 72 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Santa Maria" #1 collaborator was "NEAT - European AIDS Treatment Network" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "University of Lisbon" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 87 different institutions and companies that were collaborators in the rest 97 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Santa Maria" are "Coronary Artery Disease" (6 trials), "Cystic Fibrosis" (6 trials), "HIV Infections" (6 trials), "Multiple Myeloma" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "Hospital de Santa Maria" in a lesser frequency.

Most popular intervention types in "Hospital de Santa Maria" are "Drug" (53 trials), "Device" (25 trials), "Other" (9 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "placebo" (4 trials), "Dexamethasone" (3 trials), "IVA" (3 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Santa Maria" are 97 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Santa Maria". undefined are not yet recruiting, 17 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 68 completed trials in Hospital de Santa Maria, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Santa Maria, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 15 trials that are defined as “Not Applicable".